Literature DB >> 12898576

Report from the 4th international meeting of the attention deficit hyperactivity disorder molecular genetics network.

Stephen V Faraone1.   

Abstract

Investigators from around the world have convened annually since 1999 to share their work on the molecular genetic basis of attention deficit hyperactivity disorder (ADHD). The 4th meeting of the ADHD Molecular Genetics Network was held in May 2002. This conference began with a discussion of ongoing and proposed collaborative projects. Ongoing collaborations include the International Multi-Center ADHD Genetics (IMAGE) project, a study of additive and interactive effects of DAT1 and DRD4 on ADHD and a meta-analysis of association studies of ADHD and the DRD5 gene. A new collaborative project regarding DNA pooling was also proposed. Over 20 investigators presented recent findings from their individual research sites. Participants also broke up into working groups to discuss additional projects and topics of mutual interest, including population genetic studies using dimensional phenotypic data and a QTL approach, endophenotypes for ADHD and the genetics of ADHD in adults. Finally, participant feedback was obtained about the utility of the ADHD Molecular Genetics Network conferences and the e-mail network. Although technological and statistical advances in the field of molecular genetics have allowed researchers to begin to identify specific genes that are associated with ADHD, continued collaborative efforts are needed to fully elucidate the genetic underpinnings of this complex phenotype. Data collected at the current conference indicate that the ADHD Molecular Genetics Network has facilitated new collaborative as well as single-site projects among ADHD researchers. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12898576     DOI: 10.1002/ajmg.b.20047

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  12 in total

1.  The impact of individual and methodological factors in the variability of response to methylphenidate in ADHD pharmacogenetic studies from four different continents.

Authors:  Guilherme Polanczyk; Stephen V Faraone; Claiton H D Bau; Marcelo M Victor; Katja Becker; Reta Pelz; Jan K Buitelaar; Barbara Franke; Sandra Kooij; Emma van der Meulen; Keun-Ah Cheon; Eric Mick; Diane Purper-Ouakil; Philip Gorwood; Mark A Stein; Edwin H Cook; Luis Augusto Rohde
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-12-05       Impact factor: 3.568

Review 2.  Understanding the complex etiologies of developmental disorders: behavioral and molecular genetic approaches.

Authors:  Erik G Willcutt; Bruce F Pennington; Laramie Duncan; Shelley D Smith; Janice M Keenan; Sally Wadsworth; John C Defries; Richard K Olson
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

Review 3.  Measured gene-by-environment interaction in relation to attention-deficit/hyperactivity disorder.

Authors:  Joel Nigg; Molly Nikolas; S Alexandra Burt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-05-05       Impact factor: 8.829

Review 4.  The next challenge for psychiatric genetics: characterizing the risk associated with identified genes.

Authors:  Danielle M Dick; Richard J Rose; Jaakko Kaprio
Journal:  Ann Clin Psychiatry       Date:  2006 Oct-Dec       Impact factor: 1.567

Review 5.  Emerging association between addictive gaming and attention-deficit/hyperactivity disorder.

Authors:  Aviv Weinstein; Abraham Weizman
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 6.  Molecular genetics of attention-deficit/hyperactivity disorder: an overview.

Authors:  Tobias Banaschewski; Katja Becker; Susann Scherag; Barbara Franke; David Coghill
Journal:  Eur Child Adolesc Psychiatry       Date:  2010-02-10       Impact factor: 4.785

7.  Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).

Authors:  L Hakkaart-van Roijen; B W C Zwirs; C Bouwmans; S S Tan; T W J Schulpen; L Vlasveld; J K Buitelaar
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-05-04       Impact factor: 4.785

8.  Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes.

Authors:  Naomi Lowe; Aiveen Kirley; Ziarih Hawi; Pak Sham; Harvey Wickham; Christopher J Kratochvil; Shelley D Smith; Saretta Y Lee; Florence Levy; Lindsey Kent; Fiona Middle; Luis A Rohde; Tatiana Roman; Eda Tahir; Yanke Yazgan; Philip Asherson; Jonathan Mill; Anita Thapar; Antony Payton; Richard D Todd; Timothy Stephens; Richard P Ebstein; Iris Manor; Cathy L Barr; Karen G Wigg; Richard J Sinke; Jan K Buitelaar; Susan L Smalley; Stan F Nelson; Joseph Biederman; Stephen V Faraone; Michael Gill
Journal:  Am J Hum Genet       Date:  2004-01-19       Impact factor: 11.025

9.  Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD.

Authors:  Barbara Franke; Alejandro Arias Vasquez; Stefan Johansson; Martine Hoogman; Jasmin Romanos; Andrea Boreatti-Hümmer; Monika Heine; Christian P Jacob; Klaus-Peter Lesch; Miguel Casas; Marta Ribasés; Rosa Bosch; Cristina Sánchez-Mora; Núria Gómez-Barros; Noèlia Fernàndez-Castillo; Mònica Bayés; Anne Halmøy; Helene Halleland; Elisabeth T Landaas; Ole B Fasmer; Per M Knappskog; Angelien J G A M Heister; Lambertus A Kiemeney; J J Sandra Kooij; A Marije Boonstra; Cees C Kan; Philip Asherson; Stephen V Faraone; Jan K Buitelaar; Jan Haavik; Bru Cormand; Josep Antoni Ramos-Quiroga; Andreas Reif
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

Review 10.  The genetics of attention deficit/hyperactivity disorder in adults, a review.

Authors:  B Franke; S V Faraone; P Asherson; J Buitelaar; C H D Bau; J A Ramos-Quiroga; E Mick; E H Grevet; S Johansson; J Haavik; K-P Lesch; B Cormand; A Reif
Journal:  Mol Psychiatry       Date:  2011-11-22       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.